A few quick UPDATES
UPDATES TGTX : Today the company announced Positive Topline Results from the Phase 3 Studies for the Treatment of Patients with Multiple Sclerosis (MS) disease. The results seems outstanding. It plans to release details data in Q1 2021 and plan to submit for FDA approval in first half of 2021. The stock went was up 41% today. I still feel this company has the scope to go further up. EDIT: Gene editing company went up 32% today and has been on the upward move this week (up almost 90%). The company released its data on Sickel Cell patients and Wall Street expects it to be promising. The stock may still go up but could be risky unless somebody keeps a long term perspective. NIO : issuing 60 million shares as secondary offering at a price of $44.01. We may see a small correction here. It may give the opportunity to add to position. IPO Market is parabolic: T he IPO market is parabolic and getting scary!! For example, Airbnb ( ABNB ) went publi...
